Born in Milan October 14, 1955, Sergio Dompé Group's President eponymous biopharmaceuticals, focused on the development of innovative therapeutic solutions for rare diseases, often orphan care. Entrepreneur of the Pharmaceutical and Biotechnology industry, have been conferred, in 1996, an Honorary Degree in Biotechnology with pharmaceutical address (Bologna), in 2005 in Medical Biotechnology (L'Aquila) and 2010 in Pharmacy (Urbino). Among the first in Italy to realize the true value of biotechnology applied to human health, it developed a dense network of partnerships with the most important research centers in diseases in the therapeutic areas in which concentrates its efforts Dompé. To date, Dompé has consolidated its commitment to R & D by promoting 21 clinical trials involving 1,200 patients worldwide, conducted in collaboration with an international network of 200 research centers. In 2016 finances and gives life to Movendo Company, an innovative medical company founded by the Italian Institute of Technology to develop the most advanced technologies in the service and products in the field of rehabilitation. In 2016 Sergio Dompé has been awarded the Foundation Aid to Research in Rare Diseases Award (ARMR), an award given to people who have distinguished themselves for their commitment in research, understood as a living witness.